According to a 2014 study conducted by The Human Rights Campaign, the largest LGBTQ civil rights advocacy group in the U.S., 53% of all LGBTQ workers nationwide "hide who they are in the workplace."
Here are the Lions Health winners in the pharma category.
Since the inception of the award in 2014, the pharma Grand Prix has only been awarded twice.
It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.
As global advertisers cut their spending, should the agency world take a hard look in the mirror?
MM&M asked the pharma marketing community at large, via social media and other efforts, to provide its POV on equality, diversity, and inclusion.
New study finds early-stage breast cancer may not need chemo; Merck's Keytruda succeeds in more studies; Athenahealth CEO faces allegations of inappropriate behavior
A UK drug regulator has ruled that a 2017 press release from AstraZeneca was "misleading" as data "had not been presented in a balanced way", following a complaint from a fellow pharma firm.
As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.
Insys founder John Kapoor has maintained his innocence in the face of charges.
Alisa Lask is VP and GM, U.S. aesthetic business unit of Galderma, Nestlé Skin Health.
Elena Cant is VP, global head of vaccine commercial, Takeda Vaccine Business Unit of Takeda.
Meghan Rivera is VP, digital customer engagement of Amag Pharmaceuticals.
Wendy Blackburn is EVP, marketing and communications of Intouch Solutions.
Deborah Profit is VP, Otsuka Information Technology at Ostuka.
At MM&M's annual conference, panelists talked about how healthcare is moving toward value-based care and accelerating innovation
Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.
Whether jurors will award a pharma Grand Prix, and whether US pharma will show up, are two open questions in the run-up to Lions Health.
Here's a recap of the Novartis-Michael Cohen crisis, which unfolded this week, including how the drugmaker has responded to scrutiny over its $1.2 million contract with Cohen's firm.
At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.
Paul LeVine, VP, Analytic Services for TrialCard, describes proven strategies that prevent patient adherence fall off, driven by evidenced-based design and patient engagement programs.
Pharma giant GlaxoSmithKline has reportedly launched a review of its $1.76 billion global media agency arrangements, putting MediaCom and PHD on alert.
The healthcare sector has suffered a dip in public trust in major markets including France, India and the US, but Britons remain among the more trusting globally, according to the Edelman Health Trust Barometer.
Gary Scheiner, EVP and chief creative officer at GHG, discusses the inherent tension in day-to-day marketing for healthcare brands.
Marketers discuss the role of ad safety tech in helping pharma clients feel comfortable with ads in non-endemic media.
Remedy Health Media's Mike Collins discusses ways pharma and healthcare companies have shifted their strategies in the years after the success of blockbuster drugs.
Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.
Anatomy of Agency Culture is a supplement designed not only to showcase internal programs, but to examine them with an eye on how they impact company culture.
Croom Lawrence and Kent Groves of Merkle Health explain being human.